Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

MorphoSys AG buy ElectricPlayer

Start price
€91.28
29.12.20 / 50%
Target price
-
29.12.21
Performance (%)
-25.85%
End price
€67.68
28.06.21
Summary
This prediction ended on 28.06.21 with a price of €67.68. The prediction for MorphoSys AG disappointed with a performance of -25.85%. ElectricPlayer has 50% into this prediction

MorphoSys is a German biopharmaceutical company that develops innovative therapies for the treatment of cancer, autoimmune diseases, and other serious illnesses. The company specializes in developing monoclonal antibodies, which are highly specific and targeted therapies that recognize and bind to specific cancer cells or disease-causing proteins in the body. MorphoSys has a diverse pipeline of products in various stages of development, including several drugs that have shown promising results in clinical trials. The company is listed on the Frankfurt and NASDAQ stock exchanges and has a market capitalization of over $4 billion.

Performance without dividends (%)
Name 1w 1m 1y 3y
MorphoSys AG 1.543% 1.543% 357.513% -11.331%
iShares Core DAX® 2.149% 5.415% 21.385% 22.595%
iShares Nasdaq 100 0.838% 1.926% 44.386% 55.330%
iShares Nikkei 225® 1.143% 2.887% 27.641% 9.481%
iShares S&P 500 1.265% 3.698% 33.327% 49.646%

Comments by ElectricPlayer for this prediction

In the thread Morphosys AG diskutieren

Buy MorphoSys AG

In the thread Trading Morphosys AG
Prediction Buy
Perf. (%) -25.85%
Target price
Change
Ends at 29.12.21

Buy beendet

Stopped prediction by ElectricPlayer for MorphoSys AG

MorphoSys AG

Start price
Target price
Perf. (%)
€92.66
20.10.20
-
04.11.21
-1.77%
24.12.20